07/09/2018
GammaTile Therapy is the Next Step in the Expansion of Cesium to Additional Markets
RICHLAND, Wash., July 09, 2018
06/19/2018
No Change Expected to Recent Strategic Initiatives that Continue to Build Momentum
Richland, Wash., June 19, 2018 ...
06/05/2018
Richland, Wash., June 05, 2018 (GLOBE NEWSWIRE) -- IsoRay, Inc. (NYSE American: ISR), a medical technology company ...
05/30/2018
IsoRay Continues to Support Innovative Techniques in Brain Cancer Treatment
RICHLAND, Wash., May 30, 2018 (GLOBE ...
05/16/2018
Key Presentation on Prostate Cancer: “Survivor Debate: Low-Intermediate Risk Prostate Cancer” will Feature Noted ...
05/11/2018
RICHLAND, Wash., May 11, 2018 (GLOBE NEWSWIRE) -- IsoRay, Inc. (NYSE American: ISR), a medical technology company ...
05/03/2018
Fifth Consecutive Quarter of Year-Over-Year Revenue Increases
RICHLAND, Wash., May 03, 2018 (GLOBE NEWSWIRE) -- ...
05/02/2018
NEW YORK, NY, May 02, 2018 (GLOBE NEWSWIRE) -- IsoRay, Inc. (NYSE American: ISR), a medical technology company and ...
04/26/2018
RICHLAND, Wash., April 26, 2018 (GLOBE NEWSWIRE) -- IsoRay, Inc. (the “Company”) (NYSE American: ISR), a medical ...
04/18/2018
RICHLAND, Wash, April 18, 2018 (GLOBE NEWSWIRE) -- IsoRay, Inc. (NYSE American: ISR), a medical technology company ...
02/08/2018
Fourth Consecutive Quarter of Year-Over-Year Revenue Increases RICHLAND, Wash., Feb. 08, 2018 (GLOBE NEWSWIRE) ...
02/08/2018
Study Demonstrates “Resection Cavity Contractions Affects Cs-131 Dose Distribution Significantly Less than that of ...
Media & Public Relations Contact
If you have questions or need help, please contact Sharon Schultz:
Sharon Schultz
Public and Media Relations